All Articles

Editorial Commentary 
Uronic acid pathway metabolites regulate mesenchymal transition and invasiveness in lung adenocarcinoma
Yingxin Zhao, Allan R. Brasier
Biotarget  
2019;
3:
19  
Editorial Commentary 
Use of a cross circulation platform to regenerate lungs with induced gastric injury
Christina C. Kao, Amit D. Parulekar
Biotarget  
2019;
3:
18  
Editorial Commentary 
The “HDL receptor” scavenger receptor class B type 1 finesses the uptake of low-density lipoproteins into the subendothelial space of arteries
Godfrey S. Getz, Catherine A. Reardon
Biotarget  
2019;
3:
17  
Editorial Commentary 
Fragmentation patterns of circulating cell-free DNA demonstrate biomarker potential for human cancers
Zhou Zhang, Wei Zhang
Biotarget  
2019;
3:
16  
Review Article 
The application of genome editing technology
Jianwei Zhu, Wenjing Ma, Ziwei Huang, Qiuyu Zhang, Xiaoying Xie, Xiaoming Yang, Hualin Sun
Biotarget  
2019;
3:
15  
Editorial Commentary 
YAP-dependent metabolic remodeling in local lymph node boosts the function of cancer cells
Toshihide Kashihara, Daniela Zablocki, Junichi Sadoshima
Biotarget  
2019;
3:
14  
Editorial Commentary 
Fatty acid oxidation (FAO) metabolic switch: metastasis in lymph nodes driven by yes-associated protein (YAP) activation
Thomas Wang, Costa Frangou, Jianmin Zhang
Biotarget  
2019;
3:
13  
Editorial Commentary 
FXR regulates intestinal stem cells response to bile acids in a high fat diet
Lee Parry, Toby J. Phesse
Biotarget  
2019;
3:
12  
Editorial Commentary 
A multi-layer post-transcriptional gene regulatory program fuels cancer angiogenesis and metastasis
Ali Nehme, Hamed S. Najafabadi, Yasser Riazalhosseini
Biotarget  
2019;
3:
11  
Editorial Commentary 
CRISPR screens and the best cancer drug targets: picking the needle out of the haystack
Francesca Pentimalli
Biotarget  
2019;
3:
10  
Editorial Commentary 
Quaking as a novel target of miR-200b to regulate tumor cell cycle progression mediated angiogenesis and metastasis
Tina H. Nguyen, Suresh K. Alahari
Biotarget  
2019;
3:
9  
Editorial Commentary 
Bronchioalveolar stem cells: the crossroads of lung regeneration
Tyler T. Cooper, David A. Hess
Biotarget  
2019;
3:
8  
Editorial Commentary 
BASCs, respiratory epithelial progenitors with geo-advantage
Hong-Long Ji, Yang Liu
Biotarget  
2019;
3:
7  
Editorial Commentary 
Proteomics—a new approach to identify targets and biomarkers for hepatocellular carcinoma?
Matthias Ocker
Biotarget  
2019;
3:
6  
Letter to the Editor 
Long noncoding RNA MALAT1 and cancer metastasis
Jongchan Kim
Biotarget  
2019;
3:
5  
Editorial Commentary 
Bronchioalveolar stem cells vindicated!
Matthew Jones, Jin-San Zhang, Saverio Bellusci
Biotarget  
2019;
3:
4  
Editorial 
What’s up with MALAT1?
Gary A. Clawson
Biotarget  
2019;
3:
3  
Editorial 
The new role of lncRNA MALAT1 as a tumor suppressor
Manuel Regouc, Martin Pichler
Biotarget  
2019;
3:
2  
Editorial 
Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising approach in tumor immunotherapy
Brigitte Neuber, Michael Schmitt
Biotarget  
2019;
3:
1  
Editorial 
From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy
Ons Mamaï, Eswari Dodagatta-Marri, Rosemary J. Akhurst
Biotarget  
2018;
2:
20  
Editorial 
The human papillomavirus vaccine: a potentially novel treatment for basaloid squamous cell carcinoma
Jason Levi Floyd, Ram Prasad
Biotarget  
2018;
2:
19  
Review Article 
Effect of mammalian target of rapamycin signaling pathway on nerve regeneration
Ziwei Huang, Jianwei Zhu, Jiacheng Sun, Wenjing Ma, Lingbin Wang, Qiuyu Zhang, Hualin Sun
Biotarget  
2018;
2:
18  
Editorial 
Simultaneous profiling of multiple genomic variations using a CRISPR-Cas9 high-throughput strategy
Pierre Cordelier
Biotarget  
2018;
2:
17  
Editorial 
Targeting the BECN1-BCL2 autophagy regulatory complex to promote longevity
Björn Stork, Natascia Ventura
Biotarget  
2018;
2:
16  
Editorial 
The complexity of the ubiquitination code is driven by bacteria
Francesca Nazio, Francesco Cecconi
Biotarget  
2018;
2:
15